Milind Javle
, Professor · University of Texas M D Anderson Cancer Center
Credentials: · · · ·
History
- 1988–1992
Doctor of Medicine
Research
The Lancet Oncology · 2020 · 904 citations
Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Journal of Clinical Oncology · 2018 · First of 29 authors · 536 citations
JAMA Oncology · 2021 · 418 citations
53 papers
50 papers · 2 as a fellow
44 papers
- GV
41 papers
38 papers · 2 as a resident
36 papers
36 papers
30 papers
Grants
- 2009–2013
Phase I Study of the BikDD Nanoparticle for Advanced Cancer of the Pancreas
National Cancer Institute · R21
Contact PI · $667.4K · University of Tx Md Anderson Can Ctr
Clinical trials
- 2023–2026
Principal investigator · Active not recruiting · Phase 3
TransThera Sciences (Nanjing), Inc.
- 2021–2024
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
Principal investigator · Completed · Phase 2
TransThera Sciences (Nanjing), Inc.
- 2019–2021
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer
Principal investigator · Withdrawn · Phase 2
M.D. Anderson Cancer Center
- 2016–2022
Olaparib in Treating Patients With Stage IV Pancreatic Cancer
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center